FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2419462920> ?p ?o ?g. }

• W2419462920 endingPage "32" @default.
• W2419462920 startingPage "1421" @default.
• W2419462920 abstract "About 130-170 million people, is estimated to be infected with the hepatitis C virus (HCV). Chronic HCV infection is one of the leading causes of liver-related death and in many countries it is the primary reason for having a liver transplant. The main aim of antiviral treatment is to eradicate the virus. Until a few years ago the only treatment strategy was based on the combination of pegylated interferon and ribavirin (PEG/RBV). However, in genotypes 1 and 4 the rates of viral response did not surpass 50%, reaching up to 80% in the rest. In 2011 approval was given for the first direct acting antiviral agents (DAA), boceprevir and telaprevir, for treatment of genotype 1, in combination with traditional dual therapy. This strategy managed to increase the rates of sustained viral response (SVR) in both naive patients and in retreated patients, but with greater toxicity, interactions and cost, as well as being less safe in patients with advanced disease, in whom this treatment can trigger decompensation or even death. The recent, accelerated incorporation since 2013 of new more effective DAA, with pan-genomic properties and excellent tolerance, besides increasing the rates of SVR (even up to 100%), has also created a new scenario: shorter therapies, less toxicity and regimens free of PEG/RBV. This has enabled their almost generalised applicability in all patients. However, it should be noted that most of the scientific evidence available is based on expert opinion, case-control series, cohort studies and phase 2 and 3 trials, some with a reduced number of patients and select groups. Few data are currently available about the use of these drugs in daily clinical practice, particularly in relation to the appearance of side effects and interactions with other drugs, or their use in special populations or persons with the less common genotypes. This situation suggests the need for the generalised implementation of registries of patients receiving antiviral therapy. The main inconvenience of these new drugs is their high cost. This necessitates selection and prioritization of candidate patients to receive them, via strategies established by the various national organs, in accordance with the recommendations of scientific societies." @default.
• W2419462920 created "2016-06-24" @default.
• W2419462920 creator A5029215471 @default.
• W2419462920 creator A5029876990 @default.
• W2419462920 creator A5046522204 @default.
• W2419462920 creator A5067834677 @default.
• W2419462920 date "2016-01-28" @default.
• W2419462920 modified "2023-10-17" @default.
• W2419462920 title "New approaches in the treatment of hepatitis C." @default.
• W2419462920 cites W1754415446 @default.
• W2419462920 cites W1804925654 @default.
• W2419462920 cites W1973675889 @default.
• W2419462920 cites W1979922467 @default.
• W2419462920 cites W1980771473 @default.
• W2419462920 cites W1983369983 @default.
• W2419462920 cites W1987928660 @default.
• W2419462920 cites W1997231897 @default.
• W2419462920 cites W2010316858 @default.
• W2419462920 cites W2010380636 @default.
• W2419462920 cites W2015052165 @default.
• W2419462920 cites W2016703647 @default.
• W2419462920 cites W2035804055 @default.
• W2419462920 cites W2037648619 @default.
• W2419462920 cites W2042063943 @default.
• W2419462920 cites W2043193067 @default.
• W2419462920 cites W2044349000 @default.
• W2419462920 cites W2078251659 @default.
• W2419462920 cites W2079315402 @default.
• W2419462920 cites W2084496380 @default.
• W2419462920 cites W2086838115 @default.
• W2419462920 cites W2092646281 @default.
• W2419462920 cites W2094778224 @default.
• W2419462920 cites W2098086677 @default.
• W2419462920 cites W2113428683 @default.
• W2419462920 cites W2113615736 @default.
• W2419462920 cites W2114985397 @default.
• W2419462920 cites W2117115804 @default.
• W2419462920 cites W2117580639 @default.
• W2419462920 cites W2118684050 @default.
• W2419462920 cites W2120733999 @default.
• W2419462920 cites W2125963799 @default.
• W2419462920 cites W2126956071 @default.
• W2419462920 cites W2127189337 @default.
• W2419462920 cites W2131964582 @default.
• W2419462920 cites W2134867985 @default.
• W2419462920 cites W2138363476 @default.
• W2419462920 cites W2143244227 @default.
• W2419462920 cites W2143559032 @default.
• W2419462920 cites W2150652264 @default.
• W2419462920 cites W2156664585 @default.
• W2419462920 cites W2156761250 @default.
• W2419462920 cites W2159739349 @default.
• W2419462920 cites W2161578383 @default.
• W2419462920 cites W2164466220 @default.
• W2419462920 cites W2222306685 @default.
• W2419462920 cites W2315634424 @default.
• W2419462920 doi "https://doi.org/10.3748/wjg.v22.i4.1421" @default.
• W2419462920 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4721977" @default.
• W2419462920 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26819511" @default.
• W2419462920 hasPublicationYear "2016" @default.
• W2419462920 type Work @default.
• W2419462920 sameAs 2419462920 @default.
• W2419462920 citedByCount "101" @default.
• W2419462920 countsByYear W24194629202016 @default.
• W2419462920 countsByYear W24194629202017 @default.
• W2419462920 countsByYear W24194629202018 @default.
• W2419462920 countsByYear W24194629202019 @default.
• W2419462920 countsByYear W24194629202020 @default.
• W2419462920 countsByYear W24194629202021 @default.
• W2419462920 countsByYear W24194629202022 @default.
• W2419462920 countsByYear W24194629202023 @default.
• W2419462920 crossrefType "journal-article" @default.
• W2419462920 hasAuthorship W2419462920A5029215471 @default.
• W2419462920 hasAuthorship W2419462920A5029876990 @default.
• W2419462920 hasAuthorship W2419462920A5046522204 @default.
• W2419462920 hasAuthorship W2419462920A5067834677 @default.
• W2419462920 hasBestOaLocation W24194629201 @default.
• W2419462920 hasConcept C126322002 @default.
• W2419462920 hasConcept C203014093 @default.
• W2419462920 hasConcept C2522874641 @default.
• W2419462920 hasConcept C2776408679 @default.
• W2419462920 hasConcept C2776455275 @default.
• W2419462920 hasConcept C2776461080 @default.
• W2419462920 hasConcept C2776999253 @default.
• W2419462920 hasConcept C2777159539 @default.
• W2419462920 hasConcept C2778159067 @default.
• W2419462920 hasConcept C2778390639 @default.
• W2419462920 hasConcept C2780040827 @default.
• W2419462920 hasConcept C71924100 @default.
• W2419462920 hasConceptScore W2419462920C126322002 @default.
• W2419462920 hasConceptScore W2419462920C203014093 @default.
• W2419462920 hasConceptScore W2419462920C2522874641 @default.
• W2419462920 hasConceptScore W2419462920C2776408679 @default.
• W2419462920 hasConceptScore W2419462920C2776455275 @default.
• W2419462920 hasConceptScore W2419462920C2776461080 @default.
• W2419462920 hasConceptScore W2419462920C2776999253 @default.
• W2419462920 hasConceptScore W2419462920C2777159539 @default.
• W2419462920 hasConceptScore W2419462920C2778159067 @default.

• next